Cover Image

Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis

Amy Guo,1 Michael Grabner,2 Swetha Rao Palli,2 Jessica Elder,1 Matthew Sidovar,1 Peter Aupperle,1 Stephen Krieger3 1Acorda Therapeutics Inc., Ardsley, New York, NY, USA; 2HealthCore Inc., Wilmington, DE, USA; 3Corinne Goldsmith Dickinson Center for MS, Icahn School of Medicine at Mount Sina...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guo A (Author), Grabner M (Author), Palli SR (Author), Elder J (Author), Sidovar M (Author), Aupperle P (Author), Krieger S (Author)
Format:	Book
Published:	Dove Medical Press, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis
by: Jara M, et al.
Published: (2014)

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system
by: Rui Xiong, et al.
Published: (2023)

Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study
by: Prudence Plummer, et al.
Published: (2022)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
by: Schroeder KM, et al.
Published: (2019)

Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
by: Celine Miyazaki, et al.
Published: (2024)

Impact on healthcare resource utilization of multiple sclerosis in Spain
by: Antoni Sicras-Mainar, et al.
Published: (2017)

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
by: Kwaku Marfo, et al.
Published: (2023)

Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form
by: Dipali Bagal, et al.
Published: (2021)

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study
by: Ness, Nils-Henning, et al.
Published: (2020)

Oxybutynin extended release for the management of overactive bladder: a clinical review
by: AM Arisco, et al.
Published: (2009)

Data resource profile: Norwegian Databases for Drug Utilization and Pharmacoepidemiology
by: Hilchen Thode Sommerschild, et al.
Published: (2021)

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
by: Bloomgren G, et al.
Published: (2012)

Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
by: Fiske WD, et al.
Published: (2011)

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
by: Bonafede MM, et al.
Published: (2013)

Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
by: Caroline Amand, et al.
Published: (2018)

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany
by: Watson C, et al.
Published: (2017)

Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine
by: Rossiter LF, et al.
Published: (2020)

Formulation and evaluation of new oxycodone extended release multiple unit pellet system
by: Husár Š., et al.
Published: (2019)

Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
by: K. Arnold Chan, et al.
Published: (2020)

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin
by: Olatoke O, et al.
Published: (2022)

Association between smoking habits and dental care utilization and cost using administrative claims database and specific medical check-up data
by: Kahori Kawamura, et al.
Published: (2022)

Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients
by: Freeman L, et al.
Published: (2021)

Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
by: Burks J, et al.
Published: (2017)

Extended Medicaid coverage will improve access but insufficient to enhance postpartum care utilization: a secondary analysis of the 2016-2019 Arizona Medicaid claims
by: Abidemi Okechukwu, et al.
Published: (2024)

Analysis of the evidence-practice gap to facilitate proper medical care for the elderly: investigation, using databases, of utilization measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)
by: Takeo Nakayama, et al.
Published: (2017)

Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis
by: Sonja Ständer, et al.
Published: (2020)

A strategy to identify event specific hospitalizations in large health claims databases
by: Joshua Lambert, et al.
Published: (2022)

Confluent and reticulated papillomatosis treated with extended-release minocycline
by: Fathima Shafi, et al.
Published: (2023)

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries
by: Yamabe K, et al.
Published: (2019)

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis
by: Reinhardt Maximilian, et al.
Published: (2021)

Neutrophil-released enzymes can influence composition of circulating immune complexes in multiple sclerosis
by: S. Paryzhak, et al.
Published: (2018)

Generalized pustular psoriasis in Brazil: A public claims database studyCapsule Summary
by: Gleison Vieira Duarte, MD, et al.
Published: (2022)

Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims
by: Samer Haidar, et al.
Published: (2023)

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
by: Weycker Derek, et al.
Published: (2013)

The Economic Burden of Stroke Based on South Korea's National Health Insurance Claims Database
by: Yu-Jin Cha
Published: (2018)

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
by: Tokunaga K, et al.
Published: (2021)

Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
by: Craig V. Towers, et al.
Published: (2020)

Design and evaluation of nicorandil extended-release tablet
by: Ju-Young Kim, et al.
Published: (2015)

Treatment of ADHD: Guanfacine Extended Release in ADHD
by: J Gordon Millichap, et al.
Published: (2014)

Evaluation of immunotoxicity of the extended-release form of Afobazol
by: L. P. Kovalenko, et al.
Published: (2021)